文献速递冠心病

医院对急性心肌梗死基于疾病死亡率与手术死亡率的评估表现比较

Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.
PubMed 文献 · JAMA Cardiol · 2020-01-01

该研究比较了625家同时参与Chest Pain-MI和CathPCI注册的医院中,急性心肌梗死(AMI)基于疾病的超额死亡率比(EMR-D)与经皮冠状动脉介入治疗(PCI)基于手术的超额死亡率比(EMR-P)的相关性和重分类情况,发现两者仅中度相关(ρ=0.53),且近半数高绩效医院在换用指标后降级;在合并心源性休克或心脏骤停的患者中,手术死亡率低于疾病死亡率。

要点

  • AMI基于疾病与基于PCI手术的医院死亡率仅中度相关(ρ=0.53)。
  • 疾病死亡率高绩效医院中43.3%在手术死亡率评估中降级。
  • 合并心源性休克或心脏骤停时手术死亡率低于疾病死亡率。

核心结论

  • 对于治疗AMI的医院,手术结局与疾病结局仅中度相关。
  • 近半数PCI绩效最高三分位医院在疾病指标评估中降级。
  • 在心源性休克和/或心脏骤停患者中,疾病指标死亡率高于手术指标,提示潜在风险规避。

研究设计与样本

  • 医院层面观察性横断面多中心分析,纳入2011年4月1日至2017年12月31日Chest Pain-MI和CathPCI注册的连续成人AMI患者。

主要发现

  • 625家关联医院中,EMR-D与EMR-P的Spearman秩相关系数ρ=0.53(95%CI 0.47-0.58)。
  • 疾病风险调整死亡率最高三分位208家医院中,90家(43.3%)被分类至手术风险调整死亡率较低类别。
  • 疾病风险调整死亡率最低三分位208家医院中,92家(44.2%)被分类至手术风险调整死亡率较高类别。
  • 整体关联队列Bland-Altman图显示EMR-P与EMR-D平均差异为0.49%(95%CI -1.61%至2.58%;P<.001),手术死亡率高于疾病死亡率。
  • AMI合并心源性休克或心脏骤停患者中,EMR-P与EMR-D平均差异为-0.64%(95%CI -4.41%至3.12%;P<.001),手术死亡率低于疾病死亡率。

临床怎么用

  • 评估医院AMI救治质量时,应同时参考疾病特异性死亡率和PCI手术死亡率,避免单一手术指标导致风险规避。
  • 对合并心源性休克或心脏骤停的高危AMI患者,需关注手术死亡率指标可能低估疾病整体预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Quality of percutaneous coronary intervention (PCI) is commonly assessed by risk-adjusted mortality. However, this metric may result in procedural risk aversion, especially for high-risk patients. OBJECTIVE: To determine correlation and reclassification between hospital-level disease-specific mortality and PCI procedural mortality among patients with acute myocardial infarction (AMI). DESIGN, SETTING, AND PARTICIPANTS: This hospital-level observational cross-sectional multicenter analysis included hospitals participating in the Chest Pain-MI Registry, which enrolled consecutive adult patients admitted with a diagnosis of type I non-ST-segment elevation myocardial infarction (NSTEMI) or ST-segment elevation myocardial infarction (STEMI), and hospitals in the CathPCI Registry, which enrolled consecutive adult patients treated with PCI with an indication of NSTEMI or STEMI, between April 1, 2011, and December 31, 2017. EXPOSURES: Inclusion into the National Cardiovascular Data Registry Chest Pain-MI and CathPCI registries. MAIN OUTCOMES AND MEASURES: For each hospital in each registry, a disease-based excess mortality ratio (EMR-D) for AMI was calculated, which represents a risk-adjusted observed to expected rate of mortality for AMI as a disease using the Chest Pain-MI Registry, and a procedure-based excess mortality ratio (EMR-P) for PCI was calculated using the CathPCI Registry. RESULTS: A subset of 625 sites participated in both registries, with a final count of 776 890 patients from the Chest Pain-MI Registry (509 576 men [65.6%]; 620 981 white [80.0%]; and median age, 64 years [interquartile range, 55-74 years]) and 853 386 patients from the CathPCI Registry (582 701 men [68.3%]; 691 236 white [81.0%]; and median age, 63 years [interquartile range, 54-73 years]). Among the 625 linked hospitals, the Spearman rank correlation coefficient between EMR-D and EMR-P produced a ρ of 0.53 (95% CI, 0.47-0.58), suggesting moderate correlation. Among the highest-performing tertile for disease-based risk-adjusted mortality, 90 of 208 sites (43.3%) were classified into a lower category for procedural risk-adjusted mortality. Among the lowest-performing tertile for disease-based risk-adjusted mortality, 92 of 208 sites (44.2%) were classified into a higher category for procedural risk-adjusted mortality. Bland-Altman plots for the overall linked cohort demonstrate a mean difference between EMR-P and EMR-D of 0.49% (95% CI, -1.61% to 2.58%; P < .001), with procedural mortality higher than disease-based mortality. However, among patients with AMI complicated by cardiogenic shock or cardiac arrest, the mean difference between EMR-P and EMR-D was -0.64% (95% CI, -4.41% to 3.12%; P < .001), with procedural mortality lower than disease-based mortality. CONCLUSIONS AND RELEVANCE: This study suggests that, for hospitals treating patients with AMI, there is only a moderate correlation between procedural outcomes and disease-based outcomes. Nearly half of hospitals in the highest tertile of performance for PCI performance were reclassified into a lower performance tertile when judged by disease-based metrics. Higher rates of mortality were observed when using disease-based metrics compared with procedural metrics when assessing patients with cardiogenic shock and/or cardiac arrest, signifying what appears to be potential risk avoidance among this highest-risk subset of patients.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Nathan AS, Xiang Q, Wojdyla D, et al. Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction. JAMA Cardiol. 2020. PMID: 32347890. doi:10.1001/jamacardio.2020.0753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。